Thyroid UK has been approached about a clinical trial investigating a new drug for Graves’ disease and wondered if you or anyone else you know might be interested in taking part.
This phase I study is investigating a potential new drug, K1-70, to treat patients who have Graves’ disease, thyroid cancer, and patients who would benefit from controlling thyroid stimulating hormone receptor (TSHR) activity.
A Safety Review Committee found the drug to have been safe and well-tolerated in the patients treated so far. A further 8 patients with Graves’ disease are needed to complete this study.
Travel to and from the study sites is provided from a patient’s chosen location, as well as accommodation for patients travelling from far.
If you would like some more information or are interested in taking part please contact:
•the Volunteer Services team at the Medicines Evaluation Unit on 0800 655 6553 and quote “study MEU 15/304”.
•Recruitment Team between 8.00am and 4.00pm on 0151 706 4863 and quote “study CRU/5464” or text CRU/5464 to 07342065915.
They will be able to answer any questions you may have and book you in for a more in-depth discussion.
Thank you for taking the time to read this message and for forwarding it on to anyone you think might benefit.
Further info can be found here: healthunlocked.com/thyroidu...
